These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


348 related items for PubMed ID: 9061581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to azole antifungals.
    Marichal P, Vanden Bossche H.
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance.
    Venkateswarlu K, Denning DW, Manning NJ, Kelly SL.
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2443-6. PubMed ID: 8913443
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
    Samonis G, Maraki S, Hajiioannou I, Chatzinikolaou I, Rolston KV, Bodey GP, Kontoyiannis DP.
    J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    Ervine CM, Matthew DE, Brennan B, Houston JB.
    Drug Metab Dispos; 1996 Feb; 24(2):211-5. PubMed ID: 8742233
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    Venkateswarlu K, Denning DW, Kelly SL.
    J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
    Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E, Mårdh PA.
    J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of fluconazole resistance in Candida krusei.
    Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim AS, Ghannoum MA, Filler SG.
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2645-9. PubMed ID: 9756770
    [Abstract] [Full Text] [Related]

  • 17. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC, de Araujo CR, Costa CR, Passos XS, de Fátima Lisboa Fernandes O, do Rosário Rodrigues Silva M.
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D, Watelle M, Van der Flaes M, Nolard N.
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [Abstract] [Full Text] [Related]

  • 19. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H, Belanger P, Fratti R, Ghannoum M.
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.